CRISPR/Cas9 gene editing: a new hope for transthyretin amyloidosis treatment
-
- Shahzad
- 作成者
収録刊行物
-
- Ann. Med. Surg. (Lond.)
-
Ann. Med. Surg. (Lond.) 83 2022
